Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection

被引:52
|
作者
Shivashankar, Raina [1 ]
Khanna, Sahil [1 ]
Kammer, Patricia P. [1 ]
Harmsen, W. Scott [2 ]
Zinsmeister, Alan R. [2 ]
Baddour, Larry M. [3 ]
Pardi, Darrell S. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Div Infect Dis, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
Database Analysis; Antibiotic Resistant Bacteria; PPI Use; Risk Factor; DISEASE; VANCOMYCIN; MORTALITY; METRONIDAZOLE; PREDICTORS; THERAPY; RISK;
D O I
10.1016/j.cgh.2013.04.050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Clostridium difficile infection (CDI) can cause life-threatening complications. Severecomplicated CDI is characterized by hypotension, shock, sepsis, ileus, megacolon, and colon perforation. We created a model to identify clinical factors associated with severe-complicated CDI. METHODS: We analyzed data from 1446 inpatient cases of CDI (48.6% female; median age, 62.5 years; range, 0.1-103.7 years) at the Mayo Clinic from June 28, 2007, to June 25, 2010. Patients with severe-complicated CDI (n = 487) were identified as those who required admission to the intensive care unit or colectomy, or died, within 30 days of CDI diagnosis. Logistic regression models were used to identify variables that were independently associated with the occurrence of severe-complicated CDI in 2 cohorts. One cohort comprised all hospitalized patients; the other comprised a subset of these inpatients who were residents of Olmsted County, Minnesota to assess the association of comorbid conditions with the development of severecomplicated infection in a population-based cohort. The linear combinations of variables identified by using logistic regression models provided scores to predict the risk of developing severe-complicated CDI. RESULTS: In a multivariable model that included all inpatients, increasing age, leukocyte count >15 x 10(9)/L, increase in serum level of creatinine >1.5-fold from baseline, and use of proton pump inhibitors or narcotic medications were independently associated with severecomplicated CDI. In the secondary analysis, which included only patients from Olmsted County, comorbid conditions were not significantly associated with severe-complicated CDI. CONCLUSIONS: Older age, high numbers of leukocytes in blood samples, an increased serum level of creatinine, gastric acid suppression, and use of narcotic medications were independently associated with development of severe-complicated CDI in hospitalized patients. Early aggressive monitoring and intervention could improve outcomes.
引用
收藏
页码:1466 / 1471
页数:6
相关论文
共 50 条
  • [31] Antimicrobial-associated risk factors for Clostridium difficile infection
    Owens, Robert C., Jr.
    Donskey, Curtis J.
    Gaynes, Robert P.
    Loo, Vivian G.
    Muto, Carlene A.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S19 - S31
  • [32] Clinical and demographic profile and risk factors for Clostridium difficile infection
    Carvajal, Carlos
    Pacheco, Carlos
    Jaimes, Fabian
    BIOMEDICA, 2017, 37 (01): : 53 - 61
  • [33] Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection
    Cadena, Jose
    Thompson, George R., III
    Patterson, Jan E.
    Nakashima, Brandy
    Owens, Aaron
    Echevarria, Kelly
    Mortensen, Eric M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (04): : 350 - 355
  • [34] Risk factors for the development of Clostridium difficile infection in hospitalized children
    Samady, Waheeda
    Pong, Alice
    Fisher, Erin
    CURRENT OPINION IN PEDIATRICS, 2014, 26 (05) : 568 - 572
  • [35] Epidemiological factors influencing the development of relapsingg Clostridium difficile infection
    Vojtilova, L.
    Freibergerova, M.
    Jurankova, J.
    Bortlicek, Z.
    Husa, P.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2014, 63 (01): : 27 - 35
  • [36] Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection
    Na, Xi
    Martin, Alan J.
    Leffler, Daniel A.
    Flores, Sarah L.
    Lorraine, Kyne
    Hu, Mary
    Kelly, Ciaran P.
    GASTROENTEROLOGY, 2011, 140 (05) : S326 - S327
  • [37] Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner
    Pant, Chaitanya
    Sferra, Thomas J.
    Deshpande, Abhishek
    Minocha, Anil
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : 561 - 568
  • [38] Epidemiologic and Clinical Characteristics and Risk Factors for Severe Community-acquired Clostridium difficile Infection in Children
    Maric, Lorna Stemberger
    Nikcevic, Andrea
    Bodulic, Kristian
    Tesovic, Goran
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (09) : e322 - e324
  • [39] Predicting a complicated course of Clostridium difficile infection at the bedside
    Hensgens, M. P. M.
    Dekkers, O. M.
    Goorhuis, A.
    LeCessie, S.
    Kuijper, E. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (05) : O301 - O308
  • [40] Factors associated with prolonged symptoms and severe disease due to Clostridium difficile
    Kyne, L
    Merry, C
    O'Connell, B
    Kelly, A
    Keane, C
    O'Neill, D
    AGE AND AGEING, 1999, 28 (02) : 107 - 113